Therapies for necrotising fasciitis (Q36377217)

13 August 2017

1 reference

title

Therapies for necrotising fasciitis (English)

1 reference

13 August 2017

David Michael Aronoff

series ordinal

4

object named as

David M Aronoff

1 reference

13 August 2017

Michael H Young

1

1 reference

13 August 2017

N Cary Engleberg

series ordinal

2

1 reference

13 August 2017

Zuber D Mulla

series ordinal

3

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

Expert Opinion on Biological Therapy

13 August 2017

1 reference

13 August 2017

6

1 reference

13 August 2017

2

1 reference

13 August 2017

155-165

1 reference

Hippocrates on necrotising fasciitis

13 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Bacteriology of necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Epidemiology of invasive group a streptococcus disease in the United States, 1995-1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

The microbiology of necrotizing soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotizing soft tissue infections. Risk factors for mortality and strategies for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Value of standard laboratory tests for the early recognition of group A beta-hemolytic streptococcal necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Invasive group A streptococcal disease: risk factors for adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Ontario Group A Streptococcal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Risk factors for pediatric invasive group A streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

NSAIDS and necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Clinical presentations of soft-tissue infections and surgical site infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Massive infectious soft-tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotizing fasciitis: pathogenesis and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Rapidly advancing necrotizing fasciitis caused by Photobacterium (Vibrio) damsela: a hyperaggressive variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Widespread skin and soft-tissue infections due to two methicillin-resistant Staphylococcus aureus strains harboring the genes for Panton-Valentine leucocidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Fulminant group A streptococcal necrotizing fasciitis: clinical and pathologic findings in 7 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Severe necrotizing soft-tissue infections. Multiple disease entities requiring a common approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Molecular basis of group A streptococcal virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Pathogenesis of group A streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Epidemiologic analysis of invasive and noninvasive group a streptococcal isolates in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Distribution and sequence variations of selected virulence genes among group A streptococcal isolates from western Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Invasive group A streptococcal disease in metropolitan Atlanta: a population-based assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Molecular, serological, and clinical features of 16 consecutive cases of invasive streptococcal disease. Southeastern Minnesota Streptococcal Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Is plasminogen deployed as a Streptococcus pyogenes virulence factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Contribution of CsrR-regulated virulence factors to the progress and outcome of murine skin infections by Streptococcus pyogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Evidence for superantigen involvement in severe group a streptococcal tissue infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Virulence control in group A Streptococcus by a two-component gene regulatory system: global expression profiling and in vivo infection modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

The diagnosis of necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

The initial outpatient-physician encounter in group A streptococcal necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotizing fasciitis. Importance of roentgenographic studies for soft-tissue gas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotizing fasciitis: CT characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Deep fascial hyperintensity in soft-tissue abnormalities as revealed by T2-weighted MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Necrotising fasciitis. Immediate surgical opinion is essential

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Vacuum-assisted closure for the treatment of cervical and mediastinal necrotizing fasciitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Targeting bacterial virulence: the role of protein synthesis inhibitors in severe infections. Insights from the Society of Infectious Diseases Pharmacists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Influences of Linezolid, Penicillin, and Clindamycin, Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A Release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Treatment options in the management of necrotising fasciitis caused by Group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Pretreatment of mice with clindamycin improves survival of endotoxic shock by modulating the release of inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Caloric requirements in patients with necrotizing fasciitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Intravenous immunoglobulin as adjunctive treatment for streptococcal toxic shock syndrome associated with necrotizing fasciitis: case report and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Hyperbaric oxygen as adjuvant therapy in the management of necrotizing fasciitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Antibodies against a synthetic peptide of SagA neutralize the cytolytic activity of streptolysin S from group A streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

High-volume haemofiltration in human septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Invasive group A streptococcal infections in Florida

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Enhanced Susceptibility to Superantigen‐Associated Streptococcal Sepsis in Human Leukocyte Antigen–DQ Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

Development of Streptococcal Pyrogenic Exotoxin C Vaccine Toxoids That Are Protective in the Rabbit Model of Toxic Shock Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.6.2.155

21 January 2018

Identifiers

DOI

10.1517/14712598.6.2.155

1 reference

13 August 2017

1 reference